Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Cash from Investing Activities (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Cash from Investing Activities for 11 consecutive years, with -$52483.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Investing Activities rose 95.24% to -$52483.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$477397.0, a 70.02% increase, with the full-year FY2024 number at -$1.3 million, down 63.64% from a year prior.
  • Cash from Investing Activities was -$52483.0 for Q3 2025 at KORU Medical Systems, down from -$28814.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $50738.0 in Q4 2024 to a low of -$1.2 million in Q2 2022.
  • A 5-year average of -$307553.2 and a median of -$151357.0 in 2021 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: crashed 1711.48% in 2022, then skyrocketed 124.35% in 2024.
  • KORU Medical Systems' Cash from Investing Activities stood at -$47676.0 in 2021, then crashed by 369.57% to -$223872.0 in 2022, then rose by 6.92% to -$208388.0 in 2023, then surged by 124.35% to $50738.0 in 2024, then tumbled by 203.44% to -$52483.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Cash from Investing Activities are -$52483.0 (Q3 2025), -$28814.0 (Q2 2025), and -$446838.0 (Q1 2025).